IP Library Granted Patent US 6,868,289
Granted Patent B2
US 6,868,289 · App. 10/315,576 · Granted Mar 15, 2005

Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,868,289
App. No.
10/315,576
Granted
Mar 15, 2005
Kind
B2
Abstract

An apparatus is provided for selectively destroying dividing cells in living tissue formed of dividing cells and non-dividing cells. The dividing cells contain polarizable intracellular members and during late anaphase or telophase, the dividing cells are connected to one another by a cleavage furrow. The apparatus includes insulated electrodes to be coupled to a generator for subjecting the living tissue to electric field conditions sufficient to cause movement of the polarizable intracellular members toward the cleavage furrow in response to a non-homogeneous electric field being induced in the dividing cells. The movement of the polarizable intracellular intracellular members towards the cleavage furrow causes the breakdown thereof which adversely impacts the multiplication of the dividing cells. Preferably, an intervening member is disposed between each insulated electrode and the skin surface and each intervening member includes a conductive “floating” plate that protects against the effects on the patient from a breakdown in the insulation of the electrode.

Claims (50)

1. An apparatus for selectively destroying dividing cells in a target area of living tissue, the dividing cells having polarizable or polar or charged intracellular members, the apparatus comprising:

a first insulated electrode having a first conductor;

a second insulated electrode having a second conductor;

an electric field source connected to the first and second insulated electrodes for applying an alternating electric potential difference across the first and second conductors to create a condition in the dividing cells that encourages the destruction thereof;

an intervening member formed of a filler material disposed between one of the first and second insulated electrodes and a skin surface, the filler material having a high conductance; and

a third conductor disposed within the intervening member such that the filler material of the intervening member completely surrounds the third conductor.

2. The apparatus of claim 1 , wherein passage of the electric field through the dividing cells in late anaphase or telophase transforms the electric field into a non-homogenous electric field that produces an increased density electric field in a region of a cleavage furrow of the dividing cells, the non-homogeneous electric field produced within the dividing cells being of sufficient intensity to move the polarizable, polar or charged intracellular members toward the cleavage.

3. The apparatus of claim 1 , wherein the third conductor disposed within the intervening member comprises a flat conductor plate.

4. The apparatus of claim 1 , wherein a length of the third conductor is equal to or about equal to a length of each of the first and second conductors.

5. The apparatus of claim 1 , wherein the electric field is of sufficient frequency so that the non-homogeneous electric field produced in the dividing cells defines electric field lines which generally converge at a region of the cleavage furrow, thereby defining the increased density electric field, resulting in destruction of the dividing cells as a result of the polarizable intracellular members movement toward the cleavage furrow.

6. The apparatus of claim 1 , further including:

a first conductive lead operatively connecting the first electrode to the electric field source; and

a second conductive lead operatively connecting the second electrode to the electric field source.

7. The apparatus of claim 1 , wherein the first electrode includes a first dielectric member that is in contact with the first conductor, the first dielectric member for placement against the living tissue to form a capacitor and wherein the second electrode includes a second dielectric member that is in contact with the second conductor, the second dielectric member for placement against the living tissue to form a capacitor.

8. The apparatus of claim 1 , wherein the alternating electric potential has a frequency of between about 50 KHz to about 500 KHz.

9. The apparatus of claim 1 , wherein the alternating electric potential has a frequency of between about 100 KHz to about 300 KHz.

10. The apparatus of claim 1 , wherein the electric field is a substantially uniform electric field prior to passing through the dividing cells.

11. The apparatus of claim 1 , wherein the electric field source comprises a generator that generates an alternating voltage waveform at frequencies between about 50 KHz to about 500 KHz.

12. The apparatus of claim 11 , wherein each of the first and second electrodes are activated by the alternating voltage waveform.

13. The apparatus of claim 1 , wherein the first insulated electrode is of a first size and the second insulated electrode is of a second size that is greater than the first size, the intervening member associated with the first insulated electrode being of a smaller size than the intervening member associated with the second insulated electrode.

14. The apparatus of claim 13 , wherein the electric field near the first insulated electrode is of a higher field density than the electric field in other locations between the first and second insulated electrodes.

15. The apparatus of claim 14 , wherein the electric field tapers inwardly to the first insulated electrode.

16. The apparatus of claim 1 , wherein the intervening filler comprises a gel formed of at least one material selected from the group consisting of hydrogels, gelatins and agar.

17. The apparatus of claim 16 , wherein the gel includes salt dissolved therein to increase the conductivity of the gel.

18. An apparatus for selectively destroying dividing cells in a target area of living tissue, the dividing cells having polarizable or polar or charged intracellular members, the apparatus comprising:

a first insulated electrode having a first conductor;

a second insulated electrode having a second conductor;

an electric field source connected to the first and second insulated electrodes for applying an alternating electric potential difference across the first and second conductors to create a condition in the dividing cells that encourages the destruction thereof;

an intervening member disposed between one of the first and second insulated electrodes and a skin surface, the intervening member being formed of a filler material that has a high conductance and a high dielectric constant; and

wherein the first insulated electrode is of a first size and the second insulated electrode is of a second size that is greater than the first size, the intervening member associated with the first insulated electrode being of a smaller size than the intervening member associated with the second insulated electrode, resulting in the electric field near the first insulated electrode being of a higher field density than the electric field in other locations between the first and second insulated electrodes.

19. The apparatus of claim 18 , wherein the electric field tapers inwardly to the first insulated electrode.

20. The apparatus of claim 18 , wherein the first electrode includes a first dielectric member that is in contact with the first conductor, the first dielectric member for placement against the living tissue to form a capacitor and wherein the second electrode includes a second dielectric member that is in contact with the second conductor, the second dielectric member for placement against the living tissue to form a capacitor.

21. The apparatus of claim 18 , wherein the alternating electric potential has a frequency of between about 50 KHz to about 500 KHz.

22. The apparatus of claim 18 , wherein the alternating electric potential has a frequency of between about 100 KHz to about 300 KHz.

23. The apparatus of claim 18 , wherein the electric field is a substantially uniform electric field prior to passing through the dividing cells.

24. The apparatus of claim 18 , wherein the electric field source comprises a generator that generates an alternating voltage waveform at frequencies between about 50 KHz to about 500 KHz.

25. The apparatus of claim 18 , wherein the intervening filler comprises a gel formed of at least one material selected from the group consisting of hydrogels, gelatins and agar.

26. The apparatus of claim 25 , wherein the gel includes salt dissolved therein to increase the conductivity of the gel.

27. An apparatus for selectively destroying dividing cells in a target area of living tissue, the dividing cells having polarizable or polar or charged intracellular members, the apparatus comprising:

a first insulated electrode having a first conductor;

a second insulated electrode having a second conductor;

an electric field source connected to the first and second insulated electrodes for applying an alternating electric potential difference across the first and second conductors to create a condition in the dividing cells that encourages the destruction thereof;

an intervening member disposed each of the first and second insulated electrodes and a skin surface, each intervening member being formed of a filler material having a high conductance and a high dielectric constant; and

a third conductor disposed within the living tissue in close proximity to the target area and between the first and second insulated electrodes, the third conductor causing increased electric field density in the target area.

28. The apparatus of claim 27 , further including:

a conductor protective member that is disposed around an organ to be shielded and protected from effects of an electric field generated by the electric field source.

29. The apparatus of claim 28 , wherein the conductive protective member comprises a net formed of conductive elements that is disposed around at least a portion of the organ to be protected.

30. The apparatus of claim 27 , wherein each insulated electrode includes a conductor and a dielectric member in contact therewith and for placement against the living tissue to form a capacitor.

31. The apparatus of claim 27 , wherein the intervening filler comprises a gel formed of at least one material selected from the group consisting of hydrogels, gelatins and agar.

32. The apparatus of claim 31 , wherein the gel includes salt dissolved therein to increase the conductivity of the gel.

Assignments (18)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
SECURITY AGREEMENT Recorded Feb 20, 2013
From: NOVOCURE LIMITED
To: DEUTSCHE BANK TRUST COMPANY AMERICAS
Reel/Frame 029845/0135 →
CHANGE OF NAME Recorded May 19, 2011
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 026311/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2002
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 013564/0518 →